Safe Anti-Tuberculosis Drugs During Pregnancy
Isoniazid, rifampin, and ethambutol are the first-line anti-tuberculosis drugs that are considered safe for use during pregnancy, while streptomycin should be avoided due to its risk of fetal ototoxicity. 1
First-Line Anti-TB Drugs in Pregnancy
Safe Options
Isoniazid (INH):
Rifampin (RIF):
Ethambutol (EMB):
Drugs to Use with Caution
- Pyrazinamide (PZA):
Drugs to Avoid
Streptomycin:
Other aminoglycosides (kanamycin, amikacin) and capreomycin:
- Presumed to share streptomycin's ototoxic potential 1
- Should be avoided during pregnancy
Treatment Regimens During Pregnancy
Recommended Initial Regimen
The initial treatment regimen for pregnant women with tuberculosis should consist of:
- Isoniazid (INH)
- Rifampin (RIF)
- Ethambutol (EMB) 1
If pyrazinamide is not included, treatment should be extended to a minimum of 9 months 1.
Special Considerations
Breastfeeding:
- First-line agents (INH, RIF, EMB) pass into breast milk in small amounts but do not produce toxic effects in nursing infants 1
- Breastfeeding should not be discouraged for women on first-line agents 1
- Supplementary pyridoxine is recommended for both nursing mother and infant if the mother is taking INH 1
Monitoring:
- Regular liver function tests are essential, especially with INH
- Monthly clinical evaluations for adverse effects
- Patient education about potential side effects to decrease maternal morbidity 6
Timing of Treatment:
Second-Line Drugs in Pregnancy
For drug-resistant TB, treatment options are more limited:
Fluoroquinolones:
Ethionamide:
- Limited data, but one report described nonspecific teratogenic effects 1
- Should be avoided when possible
Cycloserine:
- Insufficient data to determine safety in pregnancy 1
Important Considerations
Counseling: Women being treated for drug-resistant TB should receive counseling about the risks to the fetus due to the known and unknown risks of second-line agents 1
Abortion: Routine therapeutic abortion is not medically indicated for pregnant women taking first-line anti-TB drugs 5
Supervised Treatment: Adherence to treatment can be especially difficult during pregnancy due to fear of medication effects and pregnancy-related nausea. Directly observed therapy (DOT) is particularly helpful in encouraging adherence 3
Treatment Timing: Treatment should not be delayed as untreated tuberculosis poses a significant threat to the mother, fetus, and family 3
By following these guidelines, tuberculosis during pregnancy can be effectively treated while minimizing risks to both mother and baby.